NOT FOR DISTRIBUTION
Header cover image

Cambridge Cognition Holdings

Market Cap

UK£40.4m

Last Updated

2021/05/09 19:41 UTC

Data Sources

Company Financials +

Executive Summary

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops digital health solutions in the United States, United Kingdom, the European Union, and internationally. More Details


Snowflake Analysis

Excellent balance sheet with weak fundamentals.

Share Price & News

How has Cambridge Cognition Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: COG is more volatile than 75% of UK stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: COG's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of UK stocks.


Market Performance


7 Day Return

7.4%

COG

-2.2%

GB Healthcare Services

2.1%

GB Market


1 Year Return

364.3%

COG

76.0%

GB Healthcare Services

26.3%

GB Market

Return vs Industry: COG exceeded the UK Healthcare Services industry which returned 75.8% over the past year.

Return vs Market: COG exceeded the UK Market which returned 26.5% over the past year.


Shareholder returns

COGIndustryMarket
7 Day7.4%-2.2%2.1%
30 Day3.2%10.8%3.5%
90 Day61.5%15.1%8.8%
1 Year364.3%364.3%78.7%76.0%31.9%26.3%
3 Year-22.4%-22.4%49.6%41.8%12.9%-0.1%
5 Year261.1%261.1%81.9%64.9%51.5%22.8%

Long-Term Price Volatility Vs. Market

How volatile is Cambridge Cognition Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Cambridge Cognition Holdings undervalued compared to its fair value and its price relative to the market?

709.99x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate COG's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate COG's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: COG is unprofitable, so we can't compare its PE Ratio to the XE Healthcare Services industry average.

PE vs Market: COG is unprofitable, so we can't compare its PE Ratio to the UK market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate COG's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: COG is overvalued based on its PB Ratio (710x) compared to the GB Healthcare Services industry average (6.6x).


Future Growth

How is Cambridge Cognition Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

28.9%

Forecasted Healthcare industry annual growth in earnings


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if COG's forecast earnings growth is above the savings rate (0.9%).

Earnings vs Market: Insufficient data to determine if COG's earnings are forecast to grow faster than the UK market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if COG's revenue is forecast to grow faster than the UK market.

High Growth Revenue: Insufficient data to determine if COG's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if COG's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Cambridge Cognition Holdings performed over the past 5 years?

-35.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: COG is currently unprofitable.

Growing Profit Margin: COG is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: COG is unprofitable, and losses have increased over the past 5 years at a rate of 35.3% per year.

Accelerating Growth: Unable to compare COG's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: COG is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (8.6%).


Return on Equity

High ROE: COG has a negative Return on Equity (-768.42%), as it is currently unprofitable.


Financial Health

How is Cambridge Cognition Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: COG's short term assets (£5.7M) do not cover its short term liabilities (£6.2M).

Long Term Liabilities: COG has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: COG is debt free.

Reducing Debt: COG has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable COG has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: COG is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 9.5% per year.


Dividend

What is Cambridge Cognition Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate COG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate COG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if COG's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if COG's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of COG's dividend in 3 years as they are not forecast to pay a notable one for the UK market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.8yrs

Average management tenure


CEO

Matthew Stork

2yrs

Tenure

UK£251,360

Compensation

Dr. Matthew Stork has been the Chief Executive Officer at Cambridge Cognition Holdings Plc since May 24, 2019 and has been its Director since May 23, 2019. He was Chief Operating Officer of Cambridge Cogni...


CEO Compensation Analysis

Compensation vs Market: Matthew's total compensation ($USD351.60K) is about average for companies of similar size in the UK market ($USD338.50K).

Compensation vs Earnings: Insufficient data to compare Matthew's compensation with company performance.


Leadership Team

Experienced Management: COG's management team is considered experienced (4.8 years average tenure).


Board Members

Experienced Board: COG's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Cambridge Cognition Holdings Plc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Cambridge Cognition Holdings Plc
  • Ticker: COG
  • Exchange: AIM
  • Founded: 2012
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: UK£40.365m
  • Shares outstanding: 31.05m
  • Website: https://www.cambridgecognition.com

Number of Employees


Location

  • Cambridge Cognition Holdings Plc
  • Tunbridge Court
  • Tunbridge Lane
  • Cambridge
  • Cambridgeshire
  • CB25 9TU
  • United Kingdom

Listings


Biography

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops digital health solutions in the United States, United Kingdom, the European Union, and internationally. The company offers CANT...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/09 19:41
End of Day Share Price2021/05/07 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.